Clinical trial
Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)
NCT00457275 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00457275 |
|---|---|
| Title | Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070) |
| Official title | A Multicentre, Open-Label, Observational Local Study to Evaluate the LDL-C Lowering Effect of Ezetimibe as Prescribed in Daily Routine Practice in the South African Population |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | MK0653, ezetimibe / Duration of Treatment: 4 Weeks |
| Enrollment | 440 |
| Start date | Apr 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Apr 6, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: